Patient info Open main menu

Pentazocine capsules BP 50 mg – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Controlled drug (Schedule 3) Details

Medicine strength:
50 mg
Contains active substance:

Patient leaflet - Pentazocine capsules BP 50 mg

1 What Pentazocine capsules are and what they are used for

This medicine has been prescribed for you for relief of moderate to severe pain. It contains pentazocine hydrochloride which belongs to a class of medicines called opioids, which are ‘pain relievers’.

This medicine has been prescribed to you and should not be given to anyone else. Opioids can cause addiction and you may get withdrawal symptoms if you stop taking it suddenly. Your doctor should have explained how long you will be taking it for, when it is appropriate to stop and how to do this safely.

Package leaflet: Information for the patient

Pentazocine 50mg Capsules

(Pentazocine Hydrochloride)

continued over page continued top of next column

continued top of next column

Date Sent:

Technologist:

Technically Approved

JDE No.:

page 2 page3 Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your doctor about your treatment.

Addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, loss of appetite, shaking, shivering or sweating. Your doctor will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop taking the medicine suddenly as you will be more likely to experience withdrawal symptoms.

Opioids should only be used by those they are prescribed for. Do not give your medicine to anyone else. Taking higher doses or more frequent doses of opioid may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.

Also talk to your doctor before taking Pentazocine capsules if you:

  • suffer from phaeochromocytoma (untreated tumour of the adrenal gland)
  • have suffered a recent heart attack
  • have high blood pressure
  • suffer from severe kidney or liver problems
  • are elderly, as you may be especially sensitive to the effects of Pentazocine
  • have a history of or suffer from fits or seizures
  • take other analgesic medicines (See “Other medicines and Pentazocine”)
  • have an underactive thyroid gland (hypothyroidism)
  • have a condition in which the adrenal glands do not produce adequate amounts of steroid hormones (adrenocortical insufficiency)
  • suffer from inflammation (swelling) of the prostate (prostatic hypertrophy)
  • suffer from inflammatory or obstructive bowel disorders
  • suffer from swelling (inflammation) of the gallbladder (cholecystitis)
  • suffer from inflammation of the pancreas (pancreatitis)
  • suffer from unexplained stomach pain
  • are taking medicines used to treat major depressive episodes, known as Monoamine Oxidase Inhibitors (MAOIs) (See “Other medicines and Pentazocine”). Treatment with Pentazocine should only be started 2 weeks after discontinuing treatment with an MAOI.

Other medicines and Pentazocine capsules

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription. This includes herbal medicines.

Medicines which may interact with or be affected by Pentazocine:

  • Antidepressant medicines known as Monoamine Oxidase Inhibitors (MAOI) in the past 2 weeks
  • Medicines which make you sleepy including:

    • Phenothiazines such as trifluoperazine,

      used to treat anxiety, mental disorders, feeling and/or being sick (nausea,

    • vomiting)
    • Tricyclic antidepressants, used to treat

      depression such as amitriptyline

    • Medicines used to improve breathing

      ability such as doxapram (respiratory stimulants)

  • Tobacco smoking may decrease the effectiveness of Pentazocine
  • Strong pain relievers such as diamorphine (heroin), morphine and naloxone.

Concomitant use of Pentazocine and sedative medicines such as benzodiazepines or related drugs increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, concomitant use should only be considered when other treatment options are not possible. However, if your doctor does prescribe Pentazocine together with sedative medicines the dose and duration of concomitant treatment should be limited by your doctor. Please tell your doctor about all sedative medicines you are taking, and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.

Pentazocine capsules with food, drink and alcohol

  • These capsules should be taken after meals
  • Do not drink alcohol while you are taking these capsules. If you drink alcohol whilst taking this medicine the sedative effect may be enhanced.

Pregnancy and breast-feeding

Pregnancy

  • Do not take Pentazocine capsules if you are pregnant or think you might be pregnant unless you have discussed this with your doctor and the benefits of treatment are considered to outweigh the potential harm to the baby.
  • If you take Pentazocine capsules during pregnancy, your baby may become dependent and experience withdrawal symptoms after the birth which may need to be treated.

Breast-feeding

  • Do not take Pentazocine capsules while you are breast-feeding as pentazocine hydrochloride passes into breast milk and will affect your baby.

2 What you need to know before you take Pentazocine capsules

Do not take Pentazocine capsules if you:

  • are allergic to pentazocine hydrochloride, analgesics or any of the other ingredients of this medicine (listed in section 6)
  • suffer from heart problems due to lung disease
  • suffer from any brain conditions (including raised pressure in the skull) or head injury
  • suffer from asthma, lung disease or have breathing difficulties, especially if you have blue discolouration of the skin (cyanosis) or cough up a lot of phlegm
  • suffer from alcoholism or are a heavy drinker
  • have porphyria (a group of rare inherited or acquired disorders where there is a problem with the production of haem (used to make haemoglobin in red blood cells) within the body).

Warnings and precautions

  • taking a pain reliever regularly for a long time may lead to a dependence (addiction)
  • taking a pain reliever too often or for too long can make headaches develop or worsen. Headaches caused by overuse of medicine should not be treated by increasing the dose.

Talk to your doctor before taking this medicine if you:

  • are or have ever been addicted to opioids, alcohol, prescription medicines, or illegal drugs
  • have previously suffered from withdrawal symptoms such as agitation, anxiety, shaking or sweating, when you have stopped taking alcohol or drugs
  • feel you need to take more Pentazocine capsules to get the same level of pain relief, this may mean you are becoming tolerant to the effects of this medicine or are becoming addicted to it. Speak to your doctor who will discuss your treatment and may change your dose or switch you to an alternative pain reliever.

Taking this medicine regularly, particularly for a long time, can lead to addiction. Your doctor should have explained how long you will be taking it for, when it is appropriate to stop and how to do this safely.

Other side effects (frequency not known)

  • Dependence and addiction (see section “How do I know if I am addicted?”)
  • High blood pressure (hypertension) or low blood pressure (hypotension)
  • Slow heartbeat (bradycardia) or fast heartbeat (tachycardia)
  • Feeling your heartbeat (palpitations)
  • Poor circulation
  • Seeing or hearing things that are not real (hallucinations) may occur occasionally
  • Feeling depressed or discontented (dysphoria)
  • Visual disturbances
  • Headache
  • Feeling disorientated
  • Mood changes
  • Nightmares
  • Difficulty sleeping (insomnia)
  • Tingling or numbness in the hands or feet (paraesthesia)
  • Fainting (syncope)
  • Intense feeling of well-being or elation (euphoria)
  • Fits (seizures)
  • Increased pressure in the skull
  • Confusion
  • Thought disturbances
  • Reddening of the face (flushing)
  • Skin rashes
  • Skin rashes with the formation of wheals (urticaria)
  • Skin rash or inflammation (dermatitis)
  • Severe itching (pruritus)
  • Constipation
  • Dry mouth
  • Pain in lower back or stomach (may be caused by a spasm of the ureter or bile duct)
  • More prone to infections due to a severe reduction in number of white blood cells (agranulocytosis)
  • Depression of the white blood cell count, which is usually reversible
  • Extremely small pupils of the eyes (miosis)
  • Breathing more slowly or weakly than usual (respiratory depression)
  • Muscle tremor
  • Chills
  • Low body temperature (hypothermia)
  • Difficulty passing urine
  • Changes in the rate or strength of uterine contractions during labour
  • Lack of sexual desire (decreased libido).

Drug Withdrawal

When you stop taking Pentazocine capsules, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating.

Driving and using machines

Pentazocine capsules may cause sedation, dizziness and occasionally euphoria. Make sure you are not affected before you drive or operate machinery.

This medicine can affect your ability to drive as it may make you sleepy or dizzy.

  • Do not drive while taking this medicine until you know how it affects you
  • It is an offence to drive if this medicine affects your ability to drive
  • However, you would not be committing an offence if:

    • The medicine has been prescribed to

      treat a medical or dental problem and

    • You have taken it according to the

      instructions given by the prescriber or in the information provided with the medicine and

    • It was not affecting your ability to drive

      safely.

Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.

Pentazocine capsules contain lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

Information on sodium content

This medicine contains less than 1 mmol sodium (23mg) per capsule, that is to say essentially ‘sodium-free’.

3 How to take Pentazocine capsules

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Your doctor should have discussed with you, how long the course of capsules will last. They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and stop taking the medicine.

Swallow the capsules with water, after meals.

The recommended dose is:

  • Adults: Initially 50mg every 4 hours followed by 50-100mg every 3 to 4 hours. Maximum daily dose of 12 capsules.
  • Elderly with damaged liver or kidneys: Your doctor may give you a smaller dose.

Use in children

  • Children under 12 years old:

    Recommended to use another dosage form such as the tablets.

    If you take more Pentazocine capsules than you should

    If you accidentally take too many capsules, contact your doctor or nearest hospital emergency department immediately for advice. Remember to take this leaflet or any remaining capsules with you.

    Symptoms of overdose include: sleepiness or drowsiness (somnolence), slower or weaker breathing (respiratory depression), low/high blood pressure (hypotension/ hypertension), faster heartbeat (tachycardia), seeing or hearing things that are not real (hallucinations), or fits (seizures, convulsions). Poor circulation and unconsciousness or coma may occur in more severe cases.

    If you forget to take Pentazocine capsules

    Do not take a double dose to make up for a forgotten dose. If you forget to take a dose, take it as soon as you remember it and then take the next dose at the right time.

    If you stop taking Pentazocine capsules

    Do not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your doctor first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating may occur if you suddenly stop taking this medicine.

    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Seek medical advice immediately if you develop the following symptoms:

  • Allergic reactions: swelling of the face, throat or tongue, difficulty breathing or dizziness
  • Frequent wheezing, breathlessness, abdominal pain, diarrhoea, fever, cough and rashes due to an increase in certain white blood cells (eosinophilia)
  • Severe blistering of the skin, mouth, eyes and genitals (toxic epidermal necrolysis).

Side effects (most frequent)

  • Feeling sick (nausea) or being sick (vomiting)
  • Feeling tired or drowsy
  • Light-headedness
  • Dizziness
  • Sweating.

    continued over page continued over page continued top of next column

continued top of next column

How do I know if I am addicted?

If you notice any of the following signs whilst taking Pentazocine capsules, it could be a sign that you have become addicted:

  • You need to take the medicine for longer than advised by your doctor
  • You feel you need to use more than the recommended dose
  • You are using the medicine for reasons other than prescribed
  • When you stop taking the medicine you feel unwell, and you feel better once taking the medicine again.

If you notice any of these signs, it is important you talk to your doctor.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www. mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Pentazocine capsules

Keep this medicine out of the sight and reach of children.

Store below 25°C in a dry place.

Do not take this medicine after the expiry date which is stated on the label/carton/ bottle. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6 Contents of the pack and other information

What Pentazocine capsules contain

  • The active substance (the ingredient that makes the capsules work) is 50mg of pentazocine hydrochloride
  • The other ingredients in the capsule are lactose, magnesium stearate, povidone
  • The capsule shell contains gelatin, titanium dioxide (E171), iron oxide (E172)
  • The printing ink contains shellac, propylene glycol, sodium hydroxide, povidone, titanium dioxide (E171).

What Pentazocine capsules look like and contents of the pack

Pentazocine capsules are orange and grey, hard gelatin capsules printed ‘C’ and the identifying letters ‘NT’ in white.

Pack sizes are 28 capsules.

Marketing Authorisation Holder and Manufacturer

Accord, Barnstaple, EX32 8NS, UK.

This leaflet was last revised in September 2023.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00142/0311

Last revision stated in the text: September 2023 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Pentazocine capsules BP 50 mg

Prescription needed? Yes, prescription-only medicine (POM)
Controlled drug
Yes, Schedule 3 of the Misuse of Drugs Regulations?
  • Controlled drugs are medicines that UK law controls more strictly because they can be misused or cause dependence. The Misuse of Drugs Regulations 2001 divide them into 5 schedules: schedule 1 has the strictest rules, schedule 5 the lightest.
  • Schedule 3 includes, for example, tramadol, gabapentin, pregabalin and buprenorphine.
  • A prescription is valid for 28 days and usually covers up to 30 days of treatment. It cannot be issued as a repeat dispensing prescription.
  • Travelling abroad: you can usually carry up to 3 months' supply. Take your prescription or a letter from your doctor to show it is yours, and check the rules of the country you are going to (GOV.UK).
  • Never give it to anyone else.
Active substance Pentazocine
Strength 50 mg
Pharmaceutical form Oral capsule
How is it taken Oral
Excipients Lactose, Magnesium stearate, Povidone, Gelatin, Titanium dioxide (E171), Iron oxide (E172), Shellac, Propylene glycol, Sodium hydroxide
Pack sizes 28 capsule
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Three years from the date of manufacture.
Storage Store below 25°C in a dry place
Drug group (ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02A Opioid analgesics
        1. N02AD Benzomorphan derivative analgesics
          1. N02AD01 pentazocine
Marketing authorisation PL 00142/0311 (first authorised 29 November 1990)
Marketing authorisation holder Accord-UK Ltd
Codes GTIN 5012617021465 · BNF 04070200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.